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Background
Early identification and diagnosis is beneficial for children with
autism spectrum disorder (ASD). Universal early screening is
recommended bymany experts, but disputed because evidence
is limited, and sensitivity and specificity in general populations
are largely unknown.
Aims
To estimate the sensitivity and specificity of early population-
based screening for ASDs.
Method
The study was based on the Norwegian Mother and Child Cohort
Study. The 36-month cohort questionnaire included the Social
Communication Questionnaire (SCQ), a 40-item screening
instrument for ASD.
Results
A total of 58 520 mothers (58%) responded to the questionnaire.
By the end of follow-up on 31 December 2015, 385 (0.7%) indi-
viduals with ASD had been identified among the responders’
children. The distributions of SCQ scores in those with ASD and
other children had large degrees of overlap.With the cut-off of 15
recommended in the SCQmanual, screening sensitivity was 20%
(95% CI 16–24) for ASD overall. For children with ASD who had
not developed phrase speech at 36 months, sensitivity was 46%
(95% CI 35–57%), whereas it was 13% (95% CI 9–17) for children
with ASD with phrase speech. Screening specificity was 99%
(95% CI 99–99). With the currently recommended cut-off of 11,
sensitivity increased to 42% for ASD overall (95% CI 37–47), 69%
(95% CI 58–79) for ASD without phrase speech and 34% (95% CI
29–40) for ASDwith phrase speech. Specificity was then reduced
to 89% (95% CI 89–90).
Conclusions
Early ASD screening with a parent checklist had low sensitivity. It
identified mainly individuals with ASD with significant develop-
mental delay and captured very few children with ASD with
cognitive skills in the normal range. Increasing sensitivity was not
possible without severely compromising specificity.
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Autism spectrum disorder (ASD) are neurodevelopmental disor-
ders characterised by persistent impairment in reciprocal social
communication and social interaction, and restricted, repetitive pat-
terns of behaviour, interests and activities.1 Symptoms usually
present at an early age, typically during the second year of life.1
Early identification and diagnosis is assumed to be beneficial,
because it facilitates access to interventions that may improve the
child’s long-term developmental outcomes.2 It may also be helpful
in obtaining immediate assistance to children and their families.2
However, universal ASD screening is controversial and the evidence
supporting such screening is weak. The current guidelines from
the American Academy of Pediatrics state that ASD screening
should be included in general developmental check-ups at ages
18 and 24 months.2 The British guidelines, on the other hand, do
not recommend universal ASD screening.3
Screening tools for ASD
A number of screening tools for ASD are available. For children
under 30 months of age, the most widely used is the Modified
Checklist for Autism in Toddlers, Revised with Follow-Up
(M-CHAT-R/F).4 The M-CHAT-R/F includes a standardised
questionnaire and an additional follow-up interview for those who
score above a defined threshold on the questionnaire. In a popula-
tion-based study of 15 612 children aged 16–30 months in the
USA, the M-CHAT-R/F had a positive predictive value of 47.5%
for ASD and 94.6% for all types of developmental concerns and
delays.4
A recent review by the US Preventive Services Task Force of
published studies of universal ASD screening in children below 36
months of age noted the lack of follow-up to identify false nega-
tives.5 Without this information, it has not been possible to estimate
sensitivity and specificity of screening instruments, and therefore
not possible to fully assess the effectiveness of ASD screening.
This was also a limitation of the large study of the M-CHAT-R/F,
which did not include complete follow-up of the screen-negative
children.4 Furthermore, it is not well-known whether screening
performance is modified by other characteristics of the child and
the family, and whether there are disadvantages in implementing
universal screening for ASD.
Consequently, we do not know whether existing screening tools
for ASD comply with the screening criteria recommended by the
World Health Organization.6 According to these criteria, health
screening should not be implemented unless it has been demon-
strated that the screening test is effective and that the benefits of
screening outweigh the harm and the costs.
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Aims
In this study, we have estimated the sensitivity and specificity of the
Social Communication Questionnaire (SCQ) for ASD screening at
36 months of age.7 The SCQ is a 40-item questionnaire that was ini-
tially designed for ASD screening in individuals aged 4 years and
older.7 Our study was conducted in the Norwegian Mother and
Child Cohort (MoBa).8 The cohort participants have been followed




MoBa is a nationwide, prospective, population-based cohort that
includes 114 552 children born from 1999 to 2009.8 Mothers were
recruited at the ultrasound examination provided free of charge to
all pregnant women around gestational week 18. Of the women
invited to participate, 41% consented. Fathers were also invited to
participate if the mothers had consented first. The parents com-
pleted questionnaires during pregnancy, and have continued to
receive questionnaires as the children grow older. Children with
ASD diagnoses have been identified and ascertained through the
Autism Birth Cohort (ABC) Study, a study of ASD nested within
MoBa.9
The 36-month questionnaire was distributed to MoBa partici-
pants born in 2001 and later, a total of 100 364 children. Of these,
there were 58 520 (58%) whose parents returned the questionnaire.
ASD case ascertainment has been conducted until 31 December
2015. By that time, the age range of the children whose parents com-
pleted the 36-month questionnaire was 6.5–14.7 years (mean 10.2
years).
The SCQ
The SCQ items are modified questions from the standardised diag-
nostic interview for ASD, the Autism Diagnostic Interview –
Revised (ADI-R).10 The items were selected to detect deficits in
social interaction and communication, and repetitive and stereo-
typed behaviours.7 The first SCQ item is used to determine if the
child has phrase speech. If so, the other 39 items are scored. A
total score of ≥15 is considered screen-positive for ASD. If the
child does not have phrase speech, only the 33 non-verbal items
are scored.
Previous studies of the SCQ have utilised clinic-based study
samples where children have already been diagnosed with ASD or
referred for evaluations of ASD. The manual cut-off level of 15 is
based on the initial validation study, which included participants
from 4 to 32 years of age.7 A subsequent American study showed
that the SCQ had lower sensitivity in children under 8 years com-
pared with children who were 8 years or older.11 To achieve a sen-
sitivity of 80% in children under 8 years of age, the cut-off had to be
lowered to ≥12 for children aged 5–7 years and ≥11 for children
under 5 years. More recent studies have also supported the use of
11 as the cut-off level in preschool and elementary-school
children.12,13
ASD screening in the MoBa cohort
The SCQ was embedded in the questionnaire distributed to MoBa
participants at age 36 months. When the MoBa questionnaire was
designed, there were no available screening instruments that had
been tested in 3-year-olds. The SCQ was chosen because it captures
all common symptoms of autism in children, and because the initial
validation study indicated that it performed well at age 4 years and
older.7 The investigators who initiated the screening procedures in
2004 decided not to use the seven verbal SCQ items for screening,
because they assumed that a large proportion of children with
ASD would not have developed spoken language by 3 years of
age. In order to ensure high sensitivity, it was decided to use a
more lenient cut-off level than 15, and screen-positivity for ASD
was defined by a score of ≥12 on the 33 non-verbal SCQ items.
Screen-positive children were invited to participate in a 1-day diag-
nostic assessment. A randomly selected group of age-matched con-
trols was also invited. Controls were selected every 2 weeks among
MoBa participants who had passed the age of 37.5 months during
the 2 preceding weeks.
Even though the seven verbal SCQ items were not used for
screening by the ABC Study, the data are still available. In this
article, we have included all the SCQ items in the analyses. We
have also estimated the sensitivity and specificity of the SCQ at dif-
ferent cut-off levels:
(a) the cut-off recommended by the SCQ manual: ≥15 for the 39
scored items.
(b) the cut-off recommended by more recent studies: ≥11 for the
39 scored items.
(c) the cut-off used in the ABC Study: ≥12 for the 33 non-verbal
items.
Other methods of identifying potential individuals with
ASD
In addition to screening, the ABC Study used several methods to
detect individuals with ASD in the cohort. The following partici-
pants were considered to potentially have ASD and invited to the
clinical assessments.
(a) Children referred from their physicians or parents, if there was
reason to suspect ASD. Referrals were elicited through annual
newsletters to MoBa participants and information on the
website of the Norwegian Institute of Public Health.
(b) Children whose parents reported autism, Asperger syndrome
or autistic traits in the MoBa questionnaires at ages 5 and 7
years.
(c) Children diagnosed with ASD by specialist health services. Data
from all hospitals and out-patient clinics are reported to the
Norwegian Patient Register (NPR), beginning in 2008.14
Reporting is linked to the government reimbursement system.
We conducted annual linkages between MoBa and the NPR
from 2008 to 2015 to identify MoBa participants with ASD
diagnoses. Until all MoBa children reached 36 months of age
in 2012, children with ASD diagnoses in the NPR were
invited to the clinical assessments. After that, the diagnoses
have been confirmed through medical record reviews, as
described below.
ASD case ascertainment
The clinical assessment of the ABC Study included the ADI-R and
the Autism Diagnostic Observation Schedule.15 Diagnoses were
based on the DSM-IV-TR.16 The ASD case definition included
codes 299.00 (autistic disorder), 299.80 (Asperger disorder) and
299.80 (pervasive developmental disorder not otherwise specified).
After 2012, case ascertainment has been conducted through
medical record reviews at the clinics where the diagnoses were
recorded. In Norwegian specialist health services, diagnoses are
coded according to the ICD-10.17 The ASD case definition of our
reviews included codes F84.0 (childhood autism), F84.1 (atypical
autism), F84.5 (Asperger syndrome), F84.8 (other pervasive devel-




Other factors affecting sensitivity, specificity and
screening participation
To examine whether sensitivity and specificity were affected by
other types of developmental delay, we stratified the individuals
with ASD by the presence or absence of phrase speech (reported
on the first SCQ item) and cognitive delay (IQ below 70 at cognitive
testing). We examined whether screening participation and screen-
ing performance were associated with sociodemographic character-
istics of the families: parental education, parental age, maternal
parity and maternal living status. We also examined whether
these sociodemographic characteristics were associated with chil-
dren’s risk of ASD.
Statistical analyses
First, we evaluated how well the individual SCQ items differentiated
between individuals with and without ASD. These abilities were
evaluated by likelihood ratios (LRs).18 An LR is the ratio between
the probability of a positive score in the presence of a condition
(true positivity) and the probability of a positive score in the
absence of the condition (false positivity). A high LR value indicates
a high precision of a screening item, whereas an LR value close to
one indicates that a screening item does not discriminate between
individuals with and without the condition. The ability of a test to
distinguish between ‘cases’ and ‘non-cases’ is generally considered
to be poor when LR values are lower than 2.19
We then determined sensitivity, specificity and positive and
negative predictive values of the SCQ at the different cut-off levels
described previously. We also explored the screening performance
of the SCQ through receiver operating characteristic (ROC)
curves. ROC curves were created for the SCQ total (manual) score
and for each of the three SCQ domains, i.e. communication,
social interaction and repetitive behaviours. In an ROC curve, sen-
sitivity (the true-positive proportion) is plotted on the y-axis,
whereas 1 – specificity (the false-positive proportion) is plotted on
the x-axis.18 The area under the ROC curve (AUC) is a measure
of the overall ability to differentiate between cases and non-cases,
and can be interpreted as the probability that a randomly chosen
pair of one case and one non-case will be correctly categorised.18
An AUC value of 0.9–1 is considered excellent, while 0.80–0.89 is
good and 0.70–0.79 is fair.20 Values below 0.70 are poor, and tests
with values close to 0.50 are of no value.20 Associations between
Table 1 Likelihood ratios of individual Social Communication Questionnaire itemsa
Item Domain Item content
No ASD group (n = 58 135)
Children with ASD without
phrase speech (n = 86)
Children with ASD with phrase
speech (n = 294)
Positive, % Positive, % Likelihood ratio Positive, % Likelihood ratio
1 C No phrase speech 0.9 100.0 113.6 0.0 0.0
2 C No conversation to and from 2.9 90.6 31.4 18.6 6.4
3 C Echolalia 61.7 25.3 0.4 69.2 1.1
4 C Inappropriate questions 38.2 1.2 0.0 27.1 0.7
5 C Pronoun reversal 37.6 18.1 0.5 45.5 1.2
6 C Neologisms 29.3 19.0 0.7 31.6 1.1
7 R Verbal rituals 35.1 32.1 0.9 46.2 1.3
8 R Compulsions and rituals 34.3 23.5 0.7 40.1 1.2
9 S Inappropriate facial expressions 0.3 10.6 33.9 3.1 9.8
10 S Use of other’s body to communicate 39.5 72.9 1.8 72.9 1.8
11 R Unusual preoccupations 17.4 54.1 3.1 54.1 3.1
12 R Repetitive use of objects 34.1 68.2 2.0 51.2 1.5
13 R Circumscribed interests 21.6 47.1 2.2 38.8 1.8
14 R Unusual sensory interests 8.2 27.4 3.3 27.4 3.3
15 R Hand and finger mannerisms 3.8 27.1 7.1 9.6 2.5
16 R Complex body mannerisms 76.1 47.7 0.6 69.2 0.9
17 — Self-injury 7.3 25.6 3.5 14.6 2.0
18 — Unusual attachment to objects 25.5 30.6 1.2 31.4 1.2
19 S No particular friends/best friend 38.7 83.3 2.2 55.2 1.4
20 C No social chat 3.1 78.8 25.1 12.8 4.1
21 C No imitation 5.3 40.0 7.6 7.5 1.4
22 C No pointing to express interest 3.5 42.4 12.0 6.2 1.8
23 C No gestures to request objects 27.1 43.5 1.6 38.7 1.4
24 C No nodding to indicate ‘yes’ 7.8 67.1 8.5 24.3 3.1
25 C No head shaking to indicate ‘no’ 11.9 49.4 4.1 25.3 2.1
26 S Usually no eye gaze 1.7 26.5 15.3 6.6 3.8
27 S No social smiling 1.0 10.6 11.1 1.4 1.5
28 S No showing and directing attention 1.1 20.0 18.0 2.4 2.2
29 S No offering to share 2.7 39.5 14.9 9.8 3.7
30 S No seeking to share enjoyment 0.9 19.8 23.3 3.8 4.4
31 S No offering of comfort 2.8 42.4 15.1 10.7 3.8
32 S Lack of normal social overtures 3.6 12.9 3.6 3.8 1.0
33 S Lack of normal range of facial expressions 0.1 16.5 133.8 2.1 16.9
34 C No imaginative social play 4.3 37.2 8.6 13.0 3.0
35 C No imaginative play 4.7 61.6 13.1 20.5 4.4
36 S No interest in other children 2.5 34.1 13.7 11.1 4.4
37 S No positive response to other children 2.5 16.7 6.7 10.4 4.2
38 — Usually no attention to voice 2.7 34.1 12.5 8.6 3.1
39 S No imaginative play with peers 15.7 89.5 5.7 45.9 2.9
40 S No group play 8.1 69.8 8.6 27.0 3.3
ASD, autism spectrum disorder; R, repetitive and restricted behaviour; C, communication; S, social interaction.
a. Includes all responders to the Norwegian Mother and Child Cohort 36-month questionnaire (n = 58 520), with 385 individuals with ASD: 86 without phrase speech at 36 months, 294 with
phrase speech at 36 months and 5 with missing information about phrase speech.
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screening participation, sociodemographic characteristics and ASD
diagnoses were assessed by Pearson’s χ2 tests.
Ethics
The authors assert that all procedures contributing to this work
comply with the ethical standards of the relevant national and insti-
tutional committees on human experimentation and with the
Helsinki Declaration of 1975, as revised in 2008. MoBa is regulated
under the Norwegian Health Registry Act. Written informed
consent was obtained from mothers and fathers who participate.
The consent covers linkages to health registries and reviews of
medical records. The ABC Study has approval from the Regional
Committee for Medical and Health Research Ethics for South-
East Norway. Participation in the clinical assessments of the ABC
Study was based on an additional written informed consent.
Results
By the end of follow-up, a total of 385 individuals with ASD (0.7%)
had been detected among the 58 520 children with questionnaire
data at 36 months. Of those with ASD, only 56 were detected
through screening and clinical assessments. The others were
detected through referrals (n = 20), reports of autism or Asperger
syndrome in the 5- and 7-year questionnaires (n = 18) and registry
linkages (n = 291).
There were 294 (76%) children with ASD who had developed
phrase speech at 36 months, while 86 (22%) had not. The informa-
tion about phrase speech was derived from item 1 of the SCQ. This
information was missing for 5 children with ASD (1%). Absence of
phrase speech indicates severe language delay, and was largely over-
lapping with cognitive delay (IQ<70) among the children with ASD.
Consequently, we only present results of analyses stratified by the
presence or absence of phrase speech.
In non-verbal children with ASD, mean SCQ total score was
13.7 (s.d. = 3.3). In children who were verbal with ASD, the distribu-
tion of SCQ scores had large degrees of overlap with those of chil-
dren without ASD, both for the total score and the different SCQ
domains. Mean SCQ total score for children who were verbal
with ASD was 9.3 (s.d. = 4.4), whereas the mean SCQ score for chil-
dren without ASD was 6.2 (s.d. = 3.3).
In Table 1, we show the proportions of positive responses, with
corresponding LR estimates, for each of the 40 SCQ items. The
ability to differentiate between individuals with and without ASD
varied widely. The items covering repetitive language (3–6) and
behaviours (7–8, 11–16) had high levels of endorsement in those
with ASD and the general population alike, with correspondingly
low LR values. In non-verbal children with ASD, the communica-
tion items that do not require phrase speech (20–25, 34–35) per-
formed better, with LR values above two for all items except one.
The 15 social interaction items (9–10, 19, 26–33, 36–37, 39–40)
all had LR values above two for non-verbal children with ASD,
and a majority of these items had LR values above 10.
In verbal children with ASD, the repetitive language items had
LR values close to one, which indicates a lack of ability to distinguish
these children from children without ASD. LR values were some-
what higher for the other communication items, but three out of
eight were below two. The performance of the social interaction
items was generally better in verbal children with ASD, with 11
out of 15 LR values above 2.
The majority of children with ASD scored below the cut-off
level of ≥15 recommended in the SCQ manual (Table 2). The sen-
sitivity was 20% (95% CI 16–24) for ASD as a whole. For non-verbal
ASD it was 46% (95% CI 35–57), whereas for verbal ASD it was 13%
(95% CI 9–17). Lowering the cut-off to 11 increased sensitivity to
Table 2 Sensitivity and specificity of the Social Communication Questionnaire (SCQ) at different cut-off levels (total n = 58 520)a
All children with ASD Children with ASD without phrase speech Children with ASD with phrase speech
SCQ total (manual) score ≥15b
Sensitivity (95% CI) 20 (16–24) 46 (35–57) 13 (9–17)
n/N 76/379 39/85 37/294
Specificity (95% CI) 99 (99–99) 99 (99–99) 99 (99–99)
n/N 56 977/57 738 56 977/57 738 56 977/57 738
Positive predictive value (95% CI) 9 (7–11) 5 (3–7) 5 (3–6)
n/N 76/837 39/800 37/798
Negative predictive value (95% CI) 99 (99–100) 100 (100–100) 100 (99–100)
n/N 56 977/57 280 56 977/57 023 56 977/57 234
SCQ total (manual) score ≥11b
Sensitivity (95% CI) 42 (37–47) 69 (58–79) 34 (29–40)
n/N 160/379 59/85 101/294
Specificity (95% CI) 89 (89–90) 89 (89–90) 89 (89–90)
n/N 51 637/57 738 51 637/57 738 51 637/57 738
Positive predictive value (95% CI) 3 (2–3) 1 (1–1) 2 (1–2)
n/N 160/6261 59/6160 101/6202
Negative predictive value (95% CI) 100 (100–100) 100 (100–100) 100 (100–100)
n/N 51 637/51 856 51 637/51 663 51 637/51 830
SCQ-33 score ≥12c
Sensitivity (95% CI) 25 (20–29) 64 (52–74) 13 (9–17)
n/N 93/379 54/85 37/294
Specificity (95% CI) 99 (99–99) 99 (99–99) 99 (99–99)
n/N 57 346/57 852 57 346/57 852 57 346/57 852
Positive predictive value (95% CI) 16 (13–19) 10 (7–12) 7 (5–9)
n/N 93/599 54/560 37/543
Negative predictive value (95% CI) 100 (99–100) 100 (100–100) 100 (99–100)
n/N 57 346/57 632 57 346/57 377 57 346/57 603
ASD, Autism spectrum disorder; SCQ-33, the 33 SCQ items that do not require phrase speech.
a. Includes all responders to the Norwegian Mother and Child Cohort 36-month questionnaire (n = 58 520 including 385 individuals with ASD).
b. The SCQ manual score was considered valid if there were ≤19 missing values on the SCQ items (available for 379 children with ASD).
c. The SCQ-33 score was considered valid if there were ≤16 missing values on the 33 non-verbal SCQ items (available for 379 children with ASD).
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42% (95% CI 37–47) for ASD overall, and to 69% (95% CI 58–79)
for non-verbal ASD and 34% (95% CI 29–40) for verbal
ASD. Specificity was then substantially reduced, from 99% (95%
CI 99–99) to 89% (95% CI 89–90). The positive predictive value
was reduced from 9% (95% CI 7–11) to 3% (95% CI 2–3). With
the cut-off level that was originally chosen for the ABC Study
(≥12 on the 33 non-verbal items), sensitivity was 64% (95% CI
52–74) for non-verbal ASD and 13% (95% CI 9–17) for verbal ASD.
In Fig. 1, we show ROC curves for non-verbal children with
ASD. For the communication and social interaction domains,
AUC estimates were above 0.9, indicating excellent performance.
For the repetitive behaviour domain, on the other hand, the AUC
value of 0.67 (95% CI 0.62–0.73) was poor. Still, the AUC for the
total SCQ score was 0.88 (95% CI 0.84–0.92), which is considered
good for a screening test.
ROC curves for verbal children with ASD are shown in Fig. 2.
For the total SCQ score, the AUC was 0.71 (95% CI 0.68–0.74).
This is just above the level of 0.7 that separates fair performance
from poor performance. There were no apparent cut-off levels
that would allow for both high sensitivity and high specificity.
AUC estimates were somewhat higher for the social interaction
domain, with an AUC of 0.71 (95% CI 0.68–0.74), than for the com-
munication domain, with an AUC of 0.65 (95% CI 0.62–0.68), and
the repetitive behaviour domain, with an AUC of 0.62 (95% CI
0.58–0.65).
The 36-month questionnaire also included questions about
whether the child had already been referred for evaluations by edu-
cational services, developmental disability services or child psych-
iatry services. Of the 86 non-verbal children with ASD, 71 (83%)
had been referred for services by age 3 years. Of the 294 verbal chil-
dren with ASD, only 52 (18%) had been referred at this age.
A large proportion of the cohort (42%) did not participate in the
ASD screening, since the parents did not return the 36-month ques-
tionnaire. As shown in Supplementary Table 1 available at https://
doi.org/10.1192/bjo.2019.34, the ones most likely to not respond
to the questionnaire were parents without a college or university
education, young parents andmothers who were single. Those char-
acteristics were also associated with a higher risk of having children
with ASD. Because the sensitivity was so low for ASD overall, we
have not included analyses of how screening performance may
vary across sociodemographic characteristics of the children and
their families.
Discussion
Interpretation of the main findings
We investigated the sensitivity and specificity of population-based
ASD screening with the SCQ at age 36 months. Most of the indivi-
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Fig. 1 Receiver operating characteristic (ROC) curves for the Social Communication Questionnaire (SCQ): autism spectrum disorder (ASD)
without phrase speech at 36 months.
(a) SCQ total (manual) score, area under ROC curve 0.88 (95% CI 0.84–0.92); (b) SCQ communication score, area under ROC curve 0.92 (95% CI 0.89–0.95); (c) SCQ social interaction
score, area under ROC curve 0.95 (95% CI: 0.94–0.97); (d) SCQ repetitive behaviour score; area under ROC curve 0.67 (95% CI: 0.62–0.73). Includes all responders to the Norwegian
Mother and Child Cohort 36-month questionnaire (n = 58 520). The sample includes 385 individuals with ASD: 86 without phrase speech at 36months, 294 with phrase speech at 36
months, and 5 with missing information about phrase speech. For children with ASD without phrase speech, the communication score (b) includes the eight communication items
that do not require phrase speech (items 20–25, 34–35). The social interaction score (c) includes the 15 social interaction items (items 9–10, 19, 26–33, 36–37, 39–40). The repetitive
behaviour score (d) includes the seven repetitive behaviour items that do not require phrase speech (items 8, 11–16).
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not have significant cognitive delays. Their SCQ score distributions
were largely overlapping with the distributions in those without
ASD, and there was no obvious way of achieving higher levels of
sensitivity without severely compromising specificity. Our findings
suggest that it is hard to detect these children through parental
report at this age. The ASD symptoms may be too subtle or not
yet apparent,21 or the symptoms may be underreported when
parents are not concerned or actively seeking help.22
Sensitivity was higher for the children with ASD who had not
developed phrase speech and were significantly delayed in their cog-
nitive development. Themajority of these children had already been
referred to ordinary health or educational services before screening
was conducted, suggesting that screening would not be necessary to
elicit access to services for them. Screening may still have benefits,
though, because it may accelerate the diagnostic process of differen-
tiating ASD from other developmental disorders, thus leading to
earlier initiation of adequate interventions. Another benefit,
which has not been assessed in this study, is that screening may
also detect children with other types of developmental delay.
The SCQ was originally validated for older children. It might
have performed better at older ages in this cohort, but then the ben-
efits of early identification would be reduced. The young age at
screening may explain why the SCQ questions about repetitive lan-
guage and behaviours were of little use in distinguishing individuals
with ASD from those without. Repetitive language and behaviours
are core features of ASD, but such behaviours are also common in
typically developing 3-year-olds.23 Furthermore, the fact that the
mothers were not aware that they were completing a screening
instrument for autism could have made them more likely to inter-
pret the ‘pathological’ response as favourable, i.e., as signs of the
child being active and inquisitive, and practising new skills.
The SCQ questions about social interaction and non-verbal
communication query deficits that are expected to be present at
an early age in children with ASD, such as lack of eye gaze, social
smiling or joint attention. The items of these domains had high
levels of endorsement for children with ASD with significant devel-
opmental delay, but not for the majority of those with ASD with
phrase speech. Limiting the use of SCQ to these two domains
would not substantially improve sensitivity.
In the current American guidelines, ASD screening is recom-
mended as part of general well-child visits at ages 18 and 24
months.2 The 23 items of the M-CHAT were included in the
MoBa 18-month questionnaire. Previous analyses have shown
that most children with ASD scored below the pre-defined cut-off
levels on this instrument as well.24 This suggests that screening
would not have performed any better at earlier ages, or with
another screening instrument.
The challenges of autism screening
A critical challenge in autism screening is the lack of a clear bound-
ary between the autism spectrum and the normal range of
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Fig. 2 Receiver operating characteristic (ROC) curves for the Social Communication Questionnaire (SCQ): autism spectrum disorder (ASD) with
phrase speech at 36 months.
(a) SCQ total (manual score), area under ROC curve 0.71 (95% CI 0.68–0.74); (b) SCQ communication score, area under ROC curve 0.65 (95% CI 0.62–0.68); ; (c) SCQ social interaction
score, area under ROC curve 0.71 (95% CI 0.68–0.74); (d) SCQ repetitive behaviour score, area under ROC curve 0.62 (95% CI 0.58–0.65). Includes all responders to the Norwegian
Mother and Child Cohort (MoBa) 36-month questionnaire (n = 58 520). The sample includes 385 individuals with ASD: 86 without phrase speech at 36 months, 294 with phrase
speech at 36 months and 5 with missing information about phrase speech. For children with ASDwith phrase speech, the communication score (b) includes the 13 communication
items (items 2–6, 20–25, 34–35). The social interaction score (c) includes the 15 social interaction items (items 9–10, 19, 26–33, 36–37, 39–40). The repetitive behaviour score (d)
includes the eight repetitive behaviour items (items 7–8, 11–16).
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development. Autistic traits are continuously distributed in the
population.25 The threshold for receiving a diagnosis depends on
clinical judgement, which may vary between clinicians and
change over time. In screening, the symptom scores of children
with ASD may also overlap with those of other children. These fea-
tures of the disorder suggest that it does not easily lend itself to
detection by screening, at least not for children without general
developmental delay. Many researchers and clinicians will still
argue that efforts should be made to identify children with ASD
as early as possible, because they are likely to have a lot to gain
from early intervention.5 If this is to succeed, it will require novel
approaches that move beyond screening with a uniform single-
informant checklists at a single time point.26
The harms and costs of screening must also be considered. The
currently recommended cut-off level for the SCQ score is ≥11.11
When we tested this cut-off in our analyses, the sensitivity was
42% for ASD overall and the specificity was 89%. If we had used
this cut-off in practice, 11% of all the children would have been
defined as screen-positive and required further follow-up.
Facilitating follow-up for such a large number of children would
be very expensive within the ordinary healthcare system. Another
problem is the psychological distress inflicted on so many parents
by labelling their children as ‘screen-positive for autism’ when
most of them do not have the disorder.
Another challenge of universal health screening is that those
who need it the most may be the least likely to participate. This
was illustrated by the participation in screening and clinical assess-
ments in our study, which was considerably lower than expected.
The proportions responding to the 36-month questionnaire were
considerably lower among parents with lower socioeconomic
status. The fact that the SCQ was embedded in a large questionnaire
may have contributed to the attrition. On the other hand, this is a
cohort where most participants are supposedly motivated to partici-
pate in research. Participation might have been even lower if the
screening had been conducted in a population with a higher
representation of disadvantaged parents and ethnic minorities.
The problems with low participation might have been mitigated if
ASD screening was integrated into routine clinical practice.
Nonetheless, integrating the use of the SCQ into routine clinical
practice would probably not have improved the sensitivity of
screening.
Strengths and limitations
The main strength of our study was its ability to capture false nega-
tives and thereby produce reliable estimates of sensitivity and speci-
ficity of early ASD screening with the SCQ. This allowed us to
remedy an acknowledged limitation of previous studies.5
However, the study was not primarily designed as a screening
study, and had no designated non-screened control group. This
limits our ability to quantify the costs and benefits of ASD screening.
Another limitation was the large proportion of non-responders to
the screening questionnaire. These parents had a higher risk of
having children with ASD, and the lack of data from these
parents may have led to a slight underestimation of sensitivity.
On the other hand, a number of individuals with ASD are still
undetected among the younger children in the cohort. Most of
these are likely to be verbal children with ASD with low SCQ
scores at 36 months, which will probably lead to lower estimates
of sensitivity when the cohort participants grow older.
In conclusion, early ASD screening with the SCQ had low sen-
sitivity in this study. The screening captured mainly children with
ASD with significant developmental delay, while missing those chil-
dren with ASD who had cognitive skills in the normal range.
Currently available evidence does not support universal early
screening programmes for ASD.
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